Suchergebnisse - "Herrath, M."

  1. 1

    CD4 T cell differentiation in type 1 diabetes von Walker, L. S. K., von Herrath, M.

    ISSN: 0009-9104, 1365-2249
    Veröffentlicht: England Oxford University Press 01.01.2016
    Veröffentlicht in Clinical and experimental immunology (01.01.2016)
    “… Summary Susceptibility to type 1 diabetes is associated strongly with human leucocyte antigen (HLA) genes, implicating T cells in disease pathogenesis. In …”
    Volltext
    Journal Article
  2. 2

    Progress in immune‐based therapies for type 1 diabetes von Herrath, M., Peakman, M., Roep, B.

    ISSN: 0009-9104, 1365-2249, 1365-2249
    Veröffentlicht: England Oxford University Press 01.05.2013
    Veröffentlicht in Clinical and experimental immunology (01.05.2013)
    “… Summary Immune‐based therapies that prevent type 1 diabetes or preserve metabolic function remaining at diagnosis have become a major objective for funding …”
    Volltext
    Journal Article
  3. 3
  4. 4

    Immunology in the clinic review series: focus on type 1 diabetes and viruses: the role of viruses in type 1 diabetes: a difficult dilemma von Coppieters, K. T., Wiberg, A., Tracy, S. M., von Herrath, M. G.

    ISSN: 0009-9104, 1365-2249, 1365-2249
    Veröffentlicht: Oxford, UK Blackwell Publishing Ltd 01.04.2012
    Veröffentlicht in Clinical and experimental immunology (01.04.2012)
    “… Summary OTHER THEMES PUBLISHED IN THIS IMMUNOLOGY IN THE CLINIC REVIEW SERIES Metabolic diseases, host responses, cancer, autoinflammatory diseases, allergy …”
    Volltext
    Journal Article
  5. 5

    Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group von Matthews, J.B, Staeva, T.P, Bernstein, P.L, Peakman, M, von Herrath, M

    ISSN: 0009-9104, 1365-2249, 1365-2249
    Veröffentlicht: Oxford, UK Oxford, UK : Blackwell Publishing Ltd 01.05.2010
    Veröffentlicht in Clinical and experimental immunology (01.05.2010)
    “… Like many other complex human disorders of unknown aetiology, autoimmune-mediated type 1 diabetes may ultimately be controlled via a therapeutic approach that …”
    Volltext
    Journal Article
  6. 6

    Factors impeding the discovery of an intervention‐based treatment for type 1 diabetes von von Herrath, M. G., Korsgren, O., Atkinson, M. A.

    ISSN: 0009-9104, 1365-2249, 1365-2249
    Veröffentlicht: England Oxford University Press 01.01.2016
    Veröffentlicht in Clinical and experimental immunology (01.01.2016)
    “… Summary Type 1 diabetes (T1D) is one of the most common and severe chronic diseases affecting both children and adults. The aetiology of the disease remains …”
    Volltext
    Journal Article
  7. 7

    Translational Mini-Review Series on Type 1 Diabetes: Immune-based therapeutic approaches for type 1 diabetes von Staeva-Vieira, T, Peakman, M, von Herrath, M

    ISSN: 0009-9104, 1365-2249
    Veröffentlicht: Oxford, UK Oxford, UK : Blackwell Publishing Ltd 01.04.2007
    Veröffentlicht in Clinical and experimental immunology (01.04.2007)
    “… Type 1 diabetes (T1D) is often considered the prototype organ-specific autoimmune disease in clinical immunology circles. The key disease features - precise …”
    Volltext
    Journal Article
  8. 8

    Dimorphic histopathology of long-standing childhood-onset diabetes von Gianani, R, Campbell-Thompson, M, Sarkar, S. A, Wasserfall, C, Pugliese, A, Solis, J. M, Kent, S. C, Hering, B. J, West, E, Steck, A, Bonner-Weir, S, Atkinson, M. A, Coppieters, K, von Herrath, M, Eisenbarth, G. S

    ISSN: 0012-186X, 1432-0428, 1432-0428
    Veröffentlicht: Berlin/Heidelberg Berlin/Heidelberg : Springer-Verlag 01.04.2010
    Veröffentlicht in Diabetologia (01.04.2010)
    “… Aims/hypothesis Childhood diabetes is thought to usually result from autoimmune beta cell destruction (type 1A) with eventual total loss of beta cells …”
    Volltext
    Journal Article
  9. 9

    Moving towards efficient therapies in type 1 diabetes: To combine or not to combine? von Bresson, D., von Herrath, M.

    ISSN: 1568-9972, 1568-9972
    Veröffentlicht: Netherlands Elsevier B.V 01.04.2007
    Veröffentlicht in Autoimmunity reviews (01.04.2007)
    “… Every year, thirty thousand people worldwide are diagnosed with type 1 diabetes mellitus (T1DM). T1DM, also called autoimmune diabetes, is a multifactorial …”
    Volltext
    Journal Article
  10. 10

    Emerging immune therapies in type 1 diabetes and pancreatic islet transplantation von Schneider, D. A., Kretowicz, A. M., von Herrath, M. G.

    ISSN: 1462-8902, 1463-1326, 1463-1326
    Veröffentlicht: Oxford, UK Blackwell Publishing Ltd 01.07.2013
    Veröffentlicht in Diabetes, obesity & metabolism (01.07.2013)
    “… In type 1 diabetes (T1D) the immune system attacks insulin‐producing pancreatic β‐cells. Unfortunately, our ability to curb this pathogenic autoimmune response …”
    Volltext
    Journal Article
  11. 11

    IL-10 and the resolution of infections von Filippi, CM, von Herrath, MG

    ISSN: 0022-3417, 1096-9896
    Veröffentlicht: Chichester, UK John Wiley & Sons, Ltd 01.01.2008
    Veröffentlicht in The Journal of pathology (01.01.2008)
    “… Chronic viral infections pose serious health concerns, as secondary complications such as immunodeficiencies and cancers are common. Treating such infections …”
    Volltext
    Journal Article
  12. 12

    Subcutaneous insulin B:9-23/IFA immunisation induces Tregs that control late-stage prediabetes in NOD mice through IL-10 and IFNγ von Fousteri, G, Dave, A, Bot, A, Juntti, T, Omid, S, von Herrath, M

    ISSN: 0012-186X, 1432-0428
    Veröffentlicht: Berlin/Heidelberg Berlin/Heidelberg : Springer-Verlag 01.09.2010
    Veröffentlicht in Diabetologia (01.09.2010)
    “… Aims/hypothesis Subcutaneous immunisation with the 9-23 amino acid region of the insulin B chain (B:9-23) in incomplete Freund's adjuvant (IFA) can protect the …”
    Volltext
    Journal Article
  13. 13

    How viral infections enhance or prevent type 1 diabetes-from mouse to man von von Herrath, M., Filippi, C., Coppieters, K.

    ISSN: 0146-6615, 1096-9071, 1096-9071
    Veröffentlicht: Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.09.2011
    Veröffentlicht in Journal of medical virology (01.09.2011)
    “… More recent evidence shows that viral infections can enhance as well as prevent type 1 diabetes in experimental animal models [Filippi and von Herrath, 2010] …”
    Volltext
    Journal Article
  14. 14

    Anti-thymoglobulin (ATG) treatment does not reverse type 1 diabetes in the acute virally induced rat insulin promoter-lymphocytic choriomeningitis virus (RIP-LCMV) model von Bresson, D, von Herrath, M.G

    ISSN: 0009-9104, 1365-2249, 1365-2249
    Veröffentlicht: Oxford, UK Blackwell Publishing Ltd 01.03.2011
    Veröffentlicht in Clinical and experimental immunology (01.03.2011)
    “… Immune modulators such as anti-thymoglobulin (ATG) are under clinical evaluation for the treatment of type 1 diabetes (T1D). Although such agents have cured …”
    Volltext
    Journal Article
  15. 15

    P140 Les cellules alpha peuvent exprimer l’interleukine-1 (IL-1) bêta au cours du diabète de type 1 von Thivolet, C., Rodriguez Calvo, T., Von Herrath, M.

    ISSN: 1262-3636
    Veröffentlicht: Elsevier Masson SAS 01.03.2015
    Veröffentlicht in Diabetes & metabolism (01.03.2015)
    “… Le diabète 1 est une maladie bi-hormonale avec un déficit en insuline et une sécrétion de glucagon anormale. L’ensemble favorise l’instabilité glycémique. Dans …”
    Volltext
    Journal Article
  16. 16

    99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Viruses, autoimmunity and immunoregulation von Filippi, C.M, von Herrath, M.G

    ISSN: 0009-9104, 1365-2249, 1365-2249
    Veröffentlicht: Oxford, UK Oxford, UK : Blackwell Publishing Ltd 01.04.2010
    Veröffentlicht in Clinical and experimental immunology (01.04.2010)
    “… Based on studies in animal models, viral infections, in particular by enteroviruses, can accelerate or halt type 1 diabetes (T1D) development. Among factors …”
    Volltext
    Journal Article Tagungsbericht
  17. 17

    Incidental CD8 T cell reactivity against caspase‐cleaved apoptotic self‐antigens from ubiquitously expressed proteins in islets from prediabetic human leucocyte antigen‐A2 transgenic non‐obese diabetic mice von Coppieters, K. T., Amirian, N., von Herrath, M. G.

    ISSN: 0009-9104, 1365-2249, 1365-2249
    Veröffentlicht: Oxford, UK Blackwell Publishing Ltd 01.08.2011
    Veröffentlicht in Clinical and experimental immunology (01.08.2011)
    “… Summary Apoptosis is known as a major mechanism which contributes to beta cell decay in type 1 diabetes. Commitment to this pathway generally involves …”
    Volltext
    Journal Article
  18. 18

    Taking a closer look at the pancreas von Coppieters, K, von Herrath, M

    ISSN: 0012-186X, 1432-0428, 1432-0428
    Veröffentlicht: Berlin/Heidelberg Berlin/Heidelberg : Springer-Verlag 01.12.2008
    Veröffentlicht in Diabetologia (01.12.2008)
    Volltext
    Journal Article
  19. 19

    Mouse models for Type 1 Diabetes von Van Belle, T.L., Taylor, P., von Herrath, M.G.

    ISSN: 1740-6757, 1740-6757
    Veröffentlicht: Netherlands Elsevier Ltd 01.01.2009
    Veröffentlicht in Drug discovery today. Disease models (01.01.2009)
    “… Our understanding of the genetics, aetiology and pathogenesis of Type 1 Diabetes (T1D) was propelled by the discovery of animal models of T1D in the late 1970s …”
    Volltext
    Journal Article
  20. 20

    Animal models have little to teach us about Type 1 diabetes: 2. In opposition to this proposal von Leiter, E. H., von Herrath, M.

    ISSN: 0012-186X, 1432-0428
    Veröffentlicht: Germany Springer Nature B.V 01.10.2004
    Veröffentlicht in Diabetologia (01.10.2004)
    Volltext
    Journal Article